These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 6119682)

  • 1. Effects of antihistaminic drugs in tests for antidepressant action.
    Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):321-35. PubMed ID: 6119682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of the antihistaminic drugs on the central action of 5-hydroxytryptophan in mice.
    Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1981 Nov; 33(4):459-65. PubMed ID: 6120505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychopharmacological profile of mesterolone.
    Baran L; Przegaliński E
    Pol J Pharmacol Pharm; 1981 Oct; 33(3):299-303. PubMed ID: 7198778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central action of ketotifen.
    Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1981; 33(5):503-15. PubMed ID: 7335554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The central action of carbamazepine as a potential antidepressant drug.
    Maj J; Chojnacka-Wójcik E; Lewandowska A; Tatarczyńska E; Wiczyńska B
    Pol J Pharmacol Pharm; 1985; 37(1):47-56. PubMed ID: 4041037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 8-OH-DPAT and ipsapirone in the tests used for evaluation of the antidepressant action.
    Tatarczyńska E; Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1989; 41(4):321-30. PubMed ID: 2534521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of azelastine hydrochloride, a novel anti-allergic drug, on the central nervous system.
    Kaneko T; Kitahara A; Ozaki S; Takizawa K; Yamatsu K
    Arzneimittelforschung; 1981; 31(8):1206-12. PubMed ID: 6117290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacological profile of dexamisole.
    Przegaliński E; Bigajska K; Siwanowicz J
    Pol J Pharmacol Pharm; 1980; 32(1):21-9. PubMed ID: 7454609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant activities of WEB 1881, a new nootropic agent.
    Maj J; Rogóz Z; Skuza G; Sowińska H; Nowak G
    Pol J Pharmacol Pharm; 1989; 41(5):439-52. PubMed ID: 2561889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central action of pirenzepine.
    Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1981; 33(6):615-26. PubMed ID: 6897118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressant profile of 9-methyl-2[-3-(4-phenyl-1-piperazinylpropyl)]-1,2,3,4-tetrahydro-beta- carbolin-1-one (B-193).
    Wiczyńska B; Antkiewicz-Michaluk L; Pilc A; Chojnacka-Wójcik E; Przegaliński E
    Pol J Pharmacol Pharm; 1989; 41(4):331-44. PubMed ID: 2636891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histamine in the rat brain: effect of acute and chronic treatment with tricyclic antidepressants and H1-antihistaminics.
    Nowak JZ; Zawilska J
    Pol J Pharmacol Pharm; 1985; 37(2):147-62. PubMed ID: 2413428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The lack of antidepressant properties and a potent central antiserotonin activity of Org 8282.
    Przegaliński E; Baran L; Siwanowicz J; Rawłów A
    Pol J Pharmacol Pharm; 1986; 38(4):377-84. PubMed ID: 3774630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The central action of salbutamol, a beta-agonist with a potential antidepressant activity.
    Przegalinski E; Baran L; Kedrek G
    Pol J Pharmacol Pharm; 1980; 32(4):485-93. PubMed ID: 6265886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant properties of some phosphodiesterase inhibitors.
    Przegaliński E; Bigajska K
    Pol J Pharmacol Pharm; 1983; 35(3):233-40. PubMed ID: 6194518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor.
    Dhir A; Kulkarni SK
    Eur J Pharmacol; 2007 Jul; 568(1-3):177-85. PubMed ID: 17509558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of dopamine D1 receptors and alpha1-adrenoceptors in the antidepressant-like effect of chlorpheniramine in the mouse tail suspension test.
    Hirano S; Miyata S; Onodera K; Kamei J
    Eur J Pharmacol; 2007 May; 562(1-2):72-6. PubMed ID: 17328889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Captopril lacks the antidepressant-like activity in animal models.
    Baran L; Siwanowicz J; Nowak G; Przegaliński E
    Pol J Pharmacol Pharm; 1991; 43(4):265-70. PubMed ID: 1667333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential antidepressant activity and enhancement of serotonin uptake of a new dibenzothiadiazepine derivative.
    Borsini F; Volterra G; Lecci A; Evangelista S; Mancinelli A; Cutrufo C; Parlani M; Mennini T; Barone D; Meli A
    Arzneimittelforschung; 1991 Jun; 41(6):573-80. PubMed ID: 1718290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.